US Archives - Page 20 of 215 - European Medical Journal

Pregnant patient discussing hepatitis E vaccine safety with a healthcare professional.

Hepatitis E Vaccine Data Support Pregnancy Use

Hepatitis E vaccine safety in pregnancy appears reassuring, with no detected rise in fetal loss in outbreak settings.

Patient with COPD using an inhaler during digital COPD inhaler training.

Digital COPD Training May Reduce Inhaler Errors

Digital COPD inhaler training reduced technique errors and improved assessment of inspiratory capacity in a new study.

Skin Cancer Prevention Video Targets Outdoor Workers

A culturally tailored narrative video may strengthen skin cancer prevention among Spanish-speaking Hispanic outdoor workers.

Doctor discussing rheumatoid arthritis treatment timing with a patient during a clinical consultation.

Methotrexate Delay Does Not Worsen RA Outcomes

Methotrexate delay after PCV13 did not worsen rheumatoid arthritis control over 1 year.

Patient with breast cancer resting peacefully after acupuncture therapies for insomnia support.

Acupuncture Therapies May Improve Cancer Insomnia

Acupuncture therapies improved insomnia in patients with breast cancer, with combined mindfulness and acupressure ranking highest.

Patient discussing epilepsy self-management with a healthcare professional during a neurology consultation

Epilepsy Self-Management Improves with Mood and Confidence

Epilepsy self-management improved as depression eased and self-efficacy rose during the evidence-based SMART intervention.

Conjugate vaccine technology being studied for improved influenza antibody responses

Conjugate Vaccine Boosts Influenza Response

Conjugate vaccine technology strengthened influenza antibody responses in mice, supporting broader next-generation vaccine development.

Older adult discussing metastatic NSCLC treatment options with an oncology clinician.

Metastatic NSCLC Treatment Remains Low in Older Adults

Metastatic NSCLC treatment remains underused among older adults, despite major therapeutic advances over 15 years.

Diarrhea Management in HER2-Mutant NSCLC

Oncology nurses support patients receiving targeted therapy by educating them on adverse event management. This infographic summarizes…

https://chatgpt.com/c/6a0f7ba2-cca4-83ea-b72f-b314c3deef67#:~:text=Person%20holding%20a%20warm%20drink%20to%20represent%20taste%20and%20smell%20dysfunction%20after%20immune%20checkpoint%20inhibitor%20therapy.

Taste and Smell Largely Preserved After Immunotherapy

Immune checkpoint inhibitor therapy rarely caused persistent taste and smell dysfunction in long term survivors after cancer treatment.